CA2257662A1 - Quinoline derivatives as tachykinin nk3 receptor antagonists - Google Patents
Quinoline derivatives as tachykinin nk3 receptor antagonistsInfo
- Publication number
- CA2257662A1 CA2257662A1 CA002257662A CA2257662A CA2257662A1 CA 2257662 A1 CA2257662 A1 CA 2257662A1 CA 002257662 A CA002257662 A CA 002257662A CA 2257662 A CA2257662 A CA 2257662A CA 2257662 A1 CA2257662 A1 CA 2257662A1
- Authority
- CA
- Canada
- Prior art keywords
- receptor antagonists
- tachykinin
- quinoline derivatives
- disorders
- useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002464 receptor antagonist Substances 0.000 title abstract 2
- 229940044551 receptor antagonist Drugs 0.000 title abstract 2
- 102000002003 Neurokinin-3 Receptors Human genes 0.000 title 1
- 108010040716 Neurokinin-3 Receptors Proteins 0.000 title 1
- 102000003141 Tachykinin Human genes 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
- 108060008037 tachykinin Proteins 0.000 title 1
- 101001125071 Homo sapiens Neuromedin-K receptor Proteins 0.000 abstract 1
- 208000019693 Lung disease Diseases 0.000 abstract 1
- 102100029409 Neuromedin-K receptor Human genes 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
NK3 receptor antagonists of formula (I) are useful in treating inter alia pulmonary disorders, CNS disorders and neurodegenerative disorders.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT94MI001099A ITMI941099A1 (en) | 1994-05-27 | 1994-05-27 | KINOLINIC DERIVATIVES |
ITMI94A001099 | 1994-05-27 | ||
ITMI95A000494 | 1995-03-14 | ||
ITMI950494 IT1293558B1 (en) | 1995-03-14 | 1995-03-14 | New tachykinin receptor antagonising quinoline derivs. - used for treating pulmonary disorders, CNS disorders, skin disorders, neurogenic inflammation, epilepsy and inflammatory pain,etc. |
CA002191352A CA2191352C (en) | 1994-05-27 | 1995-05-23 | Quinoline derivatives as tachykinin nk3 receptor antagonists |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002191352A Division CA2191352C (en) | 1994-05-27 | 1995-05-23 | Quinoline derivatives as tachykinin nk3 receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2257662A1 true CA2257662A1 (en) | 1995-12-07 |
CA2257662C CA2257662C (en) | 2005-03-29 |
Family
ID=27170234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002257662A Expired - Fee Related CA2257662C (en) | 1994-05-27 | 1995-05-23 | Quinoline derivatives as tachykinin nk3 receptor antagonists |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2257662C (en) |
-
1995
- 1995-05-23 CA CA002257662A patent/CA2257662C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2257662C (en) | 2005-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2191352A1 (en) | Quinoline Derivatives as Tachykinin NK3 Receptor Antagonists | |
CA2183250A1 (en) | Prodrugs of morpholine tachykinin receptor antagonists | |
CY2505B1 (en) | Quinoline derivatives as nk3 antagonists | |
WO2000035919A3 (en) | Quinoline derivatives | |
CA2198238A1 (en) | Piperidine derivatives as neurokinin antagonists | |
CA2134964A1 (en) | Bridged Aza-Bicyclic Derivatives as Substance P Antagonists | |
CA2109415A1 (en) | Substituted 3-Aminoquinuclidines | |
PL326928A1 (en) | Quinolin-4-carboxyamidic derivatives, their production and their application as antagonists ofneurokinin-3 (nk-3) and neurokinin-2 (nk-2) | |
CA2297911A1 (en) | Substituted 6-phenylphenanthridines | |
CA2250569A1 (en) | Novel phenanthridines substituted in the 6 position | |
IE902288L (en) | Tetrazolylmethylpiperidine carboxylic acid | |
CA2237189A1 (en) | 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists | |
AU3567195A (en) | Neurokinin antagonists | |
CA2064373A1 (en) | Piperidine derivatives | |
PL333079A1 (en) | Piparazinic derivatives as antagonists of neurokinin | |
CA2257662A1 (en) | Quinoline derivatives as tachykinin nk3 receptor antagonists | |
GB9323162D0 (en) | 4-(1h-2-methylimidazo(4,5-c)pyridinylmethyl)phenylsulphonamid e derivatives as antagonists of paf | |
CA2157234A1 (en) | Stereoselective process for producing dihydro-2-3-benzodiazepine derivatives | |
AU1574995A (en) | Tachykinins antagonists | |
GB9705861D0 (en) | Trypthophan ureas as neurokinin antagonists | |
NO985535L (en) | Process for the preparation of 1,3-alkanediols | |
DE69800092T2 (en) | Substituted 4- (6-fluoro- [1H] -indol-3-yl) 1,2,3,6-tetrahydropyridine derivatives for the treatment of CNS disorders | |
IE840831L (en) | 1,4-dihydropyridine derivatives | |
CA2275527A1 (en) | Novel heterocyclic substituted pyrrolidine amide derivatives | |
PL328514A1 (en) | 1,4-dihydropyridine compounds as antagonists of bradykinin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |